Journal of Clinical Endocrinology & Metabolism (JCEM)
Journal Descriptions
he Journal of Clinical Endocrinology & Metabolism is the world’s leading peer-reviewed journal for the dissemination of original research as it relates to the clinical practice of endocrinology, diabetes, and metabolism. Spanning the full spectrum of translational research from discovery science to experimental medicine and from critical evaluation of new treatments to patient-population-related outcomes, each issue provides up-to-date coverage of novel developments that enhance our understanding of the pathophysiology, diagnosis, and treatment of endocrine and metabolic disorders. JCEM also publishes articles that reveal insight into the metabolic-endocrine basis for, or treatment of, other human conditions including cardiovascular disease, cancer, and aging. Over and above new findings submitted from researchers across the globe, regular features of special interest include personal perspectives and commentaries on new developments, results of prismatic clinical trials, mini-reviews, and clinical practice guidelines. JCEM will not normally consider: Articles that fall outside of the journal’s scope of “clinical practice of endocrinology, diabetes, and metabolism” Articles that contain exclusively animal or other pre-clinical data with no evidence of clinical translation Isolated association studies that fail to demonstrate impactful reach and significance. Association studies should validate or refute experimental data included within the same article. Mendelian Randomization studies that lack a clear mechanistic basis or fail to fully comply with the requirements of the STROBE-MR checklist (see Author Guidelines) Research based mainly on self-reported patient data
Journal of Clinical Endocrinology & Metabolism (JCEM) is :-
-
International, Peer-Reviewed, Open Access, Refereed, Endokrinologie, Metabolismus, Zeitschrift , Online or Print , Monthly Journal
- UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0021-972X, E-ISSN: 1945-7197, Established: 2025, Impact Factor: 5.0
- Does Not Provide Crossref DOI
-
Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE